Regular and decaf coffee consumption is associated with a significantly lower risk of chronic liver disease, according to a large-scale prospective study published in the journal Clinical Gastroenterology and Hepatology. Researchers tracking nearly 355,000 adults over a 13-year period found that individuals consuming five or more cups of coffee daily experienced a 32 percent lower risk of cirrhosis and a 47 percent lower risk of liver cancer compared to non-coffee drinkers.
Study Details and Findings on Liver Health
The research, which utilized data from the UK Biobank biomedical database, analyzed the dietary habits and long-term health outcomes of participants to evaluate how coffee impacts hepatic function. According to lead study author Dr. Hyunseok Kim, a transplant hepatologist at Cedars-Sinai Medical Center, participants who drank coffee demonstrated lower levels of liver inflammation and higher levels of proteins indicative of healthy liver function. The protective association applied to both caffeinated and decaffeinated varieties, suggesting that non-caffeine components drive the physiological benefits.
Additional population studies support these findings. A 2021 study published in BMC Public Health analyzed data from approximately 500,000 individuals and reported a 21 percent lower risk of chronic liver disease among coffee consumers. Furthermore, research from BMJ Open involving more than 2.25 million participants indicated that drinking up to five cups of caffeinated coffee daily cut the risk of hepatocellular cancer in half.
Biological Mechanisms Behind Coffee and the Liver
Coffee contains hundreds of biologically active compounds beyond caffeine, including chlorogenic acids, polyphenols, and diterpenes. According to Dr. Kim, these phytochemicals possess antioxidant, anti-inflammatory, and anti-scarring properties that help reduce pathways involved in cellular injury and fibrosis.
Dr. Raffi Karagozian, a transplant hepatologist at Tufts Medical Center, notes that these antioxidant compounds mitigate oxidative stress that otherwise leads to chronic inflammation. Additionally, these bioactive elements slow the activity of cells responsible for fibrosis, or scarring, of the liver tissue. Beyond hepatic benefits, these identical anti-inflammatory and metabolic pathways may also contribute to a lower risk of heart disease, heart failure, and stroke, as observed in broader cardiovascular research.
The Role of Decaffeinated Coffee
Because decaffeinated coffee yields similar protective associations against liver disease, researchers emphasize that caffeine is not the primary driver of these health outcomes. Dr. Marie L. Borum, director of the Division of Gastroenterology and Liver Disease at George Washington University, points out that decaf retains polyphenols and chlorogenic acids capable of exerting antioxidant effects. While these findings support unsweetened coffee as a simple dietary strategy for liver disease prevention, hepatologists maintain that further clinical investigations are necessary to fully map out the beneficial effects of coffee consumption upon the liver.
Keep reading